Ticker Details
Bicycle Therapeutics plc
IPO Date:	May 20, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$372.51M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 2.96%
Avg Daily Range (30 D):	$0.15 | 2.45%
Avg Daily Range (90 D):	$0.19 | 2.72%

Institutional Daily Volume
Avg Daily Volume:	.22M
Avg Daily Volume (30 D):	.32M
Avg Daily Volume (90 D):	.29M

Trade Size
Avg Trade Size (Sh.):	94
Avg Trade Size (Sh.) (30 D):	96
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	1,046
Avg Institutional Trade:	$2.02M
Avg Institutional Trade (30 D):	$3.47M
Avg Institutional Trade (90 D):	$2.33M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.19M
Avg Closing Trade (30 D):	$1.34M
Avg Closing Trade (90 D):	$1.34M
Avg Closing Volume:	46.3K

News

Aug 29, 2025 @ 7:49 AM Bicycle Toxin Conjugates Clinical Trials FDA Appro... Source: Globe Newswire

Aug 27, 2025 @ 12:00 PM Maxion Therapeutics Strengthens Board with Appoint... Source: Maxion Therapeutics

Mar 3, 2025 @ 6:00 PM Advanced Urothelial Carcinoma Clinical Trial Pipel... Source: Delveinsight

Jun 27, 2024 @ 1:40 PM Are Medical Stocks Lagging Bicycle Therapeutics (... Source: Zacks Equity Research

Jun 21, 2024 @ 12:24 PM Top 5 Small-Cap Biotechnology Stocks for a Stable ... Source: Nalak Das

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.62	$-.85	$-1.14
Diluted EPS	$-3.62	$-.85	$-1.14
Revenue	$28.34M	$11.73M	$2.92M
Gross Profit
Net Income / Loss	$-250.66M	$-59.1M	$-78.95M
Operating Income / Loss	$-290.02M	$-65.55M	$-86.6M
Cost of Revenue
Net Cash Flow	$-241.78M	$-71.88M	$-73.33M
PE Ratio